Statin-induced Necrotizing Autoimmune Myopathy
Statin-induced Necrotizing Autoimmune Myopathy
复制标题
他汀类药物诱发的坏死性自身免疫性肌病
DOI:
10.14735/amcsnn2017569
复制
发表时间:
2017
影响因子:
0.5
通讯作者:
J. Bednařík
中科院分区:
文献类型:
--
作者:
Tomáš Horák;S. Voháňka;E. Tvrdíková;Magda Horáková;J. Bednařík
A 76-year-old man with a history of two prior strokes complicated by residual mild cognitive impairment, atrial fibrillation, coronary artery disease, diabetes mellitus type 2, congestive heart failure, dyslipidemia, and stage 3 chronic kidney disease was admitted for failure to thrive and functional decline. Two months prior, he had been briefly hospitalized for fatigue and inability to walk. At that time, he was found to be dehydrated and was treated for a UTI. His weakness was attributed to exhaustion from overwork and recent travel, and he was subsequently transferred to a skilled nursing facility for rehabilitation. Prior to that hospitalization he had been walking independently and actively working. After a month of rehabilitation therapy, he was able to ambulate with a walker, but he required assistance with his activities of daily living (ADLs). Upon his return home, his function progressively declined despite home physical therapy. He suffered from diarrhea, weight loss, and swallowing difficulties resulting in aspiration with food intake. He was admitted to the hospital and noted to be frail and malnourished. He was found to have liver transaminitis and an elevated creatinine kinase (CK) level of 3095 U/L (reference 63-473 U/L). A modified barium swallow study (MBSS) demonstrated an inefficient oropharyngeal swallow phase with reduced based of tongue contraction and a weak and ineffective cough. It was recommended to give him nothing by mouth (NPO). The patient subsequently aspirated and was transferred to the ICU, where he was supported with high flow nasal O2 support and was treated with intravenous antibiotics for aspiration pneumonia. Rheumatology and neurology consults were obtained, and both consultants were concerned for an inflammatory or necrotizing myositis. The patient declined components of the recommended work-up including an MRI of the brain and femur and a muscle biopsy. An EMG/NCS could not be performed due to patient fatigue. Because of the lack of objective data to support a diagnosis of necrotizing myopathy, empiric treatment with immunosuppressive agents was not initiated. The patient’s respiratory status stabilized, and he was transferred out of the ICU on hospital day 6. A percutaneous endoscopic gastrostomy tube was placed on hospital day 9. On his 11th hospital day, the patient suffered another hypoxic aspiration event and manifested findings consistent with a re-expression of his previous stroke. His respiratory status remained tenuous, and the patient decided that he did not want aggressive treatment or further testing. On his 13th hospital day, he expired. After his death, lab testing for antibody to HMG-CoA reductase result came back significantly elevated, >200 U (reference 0-19 U). Discussion
DOI:
10.1001/jama.2015.13766
发表时间:
2015-11-03
期刊:
JAMA
影响因子:
--
作者:
Kantor ED;Rehm CD;Haas JS;Chan AT;Giovannucci EL
通讯作者:
Giovannucci EL
DOI:
10.1111/jch.13797
发表时间:
2020
期刊:
Journal of clinical hypertension (Greenwich, Conn.)
影响因子:
--
作者:
Whelton,PaulK;Campbell,NormRC;Lackland,DanielT;Parati,Gianfranco;Ram,CVenkataS;Weber,MichaelA;Zhang,Xin-Hua
通讯作者:
Zhang,Xin-Hua
影响因子:
--
作者:
Christopher-Stine, Lisa;Casciola-Rosen, Livia A.;Hong, Grace;Chung, Tae;Corse, Andrea M.;Mammen, Andrew L.
通讯作者:
Mammen, Andrew L.